Protocols, physiology, and trials of hydroxyethyl starch [3]

New England Journal of Medicine

Volumn 367, Issue 13, 2012, Pages 1266-1267

  Wise, Robert ^a   Fourie, Cate ^b   Richards, Guy A ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; ISOTONIC SOLUTION;

ACUTE KIDNEY FAILURE; BODY FLUID; CENTRAL VENOUS PRESSURE; CLINICAL PROTOCOL; HUMAN; KIDNEY DYSFUNCTION; LETTER; MAIZE; OUTCOME ASSESSMENT; PATIENT SAFETY; POTATO; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; THERAPY EFFECT; FEMALE; FLUID THERAPY; MALE; NOTE; SEPSIS;

FEMALE; FLUID THERAPY; HETASTARCH; HUMANS; ISOTONIC SOLUTIONS; MALE; SEPSIS;

EID: 84866753052     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1209905     Document Type: Letter

References (4)

1. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008;134:172-8.
2. Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012;16(3):R94.
3. James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011;107:693-702.
4. Martin S, BaSES Investigators. Hydroxyethyl starch 130/0.4 versus vs 0.9% NaCl in 241 patients with severe sepsis, septic shock. Presented at the European Society of Anaesthesiology meeting, Paris, June 10, 2012. abstract.